- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06119594
Contribution of the Evaluation of Body Composition by Connected Scale in the Effectiveness of a Reconditioning Program Through Physical Activity Adapted for Patients Suffering From Chronic Diseases (COCORAPA)
The goal of this interventional study is to evaluate the impact of the use of a connected impedance scale on the physical and mental quality of life of patients suffering from chronic diseases and participating in a physical activity rehabilitation program. The main objective is to know if a regular monitoring of the evolution of body composition parameters recorded by the connected scale would allow patients participating in the Physical Activity rehabilitation program at Hôtel-Dieu to follow in real time the effects of such program, not on weight itself but on body composition, and that this would contribute to a better perception of physical and mental quality of life at the end of the program 90 Participants will be randomized in two groups :
- Control group (N = 45) : routine care
- Interventionnal group (N=45) : routine care + use of connected scale All participants will undergo physical activity rehabilitation program during 6 weeks.
Patients will be see again at 6 months, and the following parameters will be comparer between the two groups :
- SF-36 questionnaire
- Ricci & Gagnon questionnaire
- 6MWT
- 30 sec sit-to stand test
- Ito-Shirado test
- Sorensen test
- Handgrip test
- MaxV02
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75181 Paris Cedex 04
- Centre d'Investigations en Médecine du Sport - Hôpital Hôtel Dieu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient (male or female) aged 18 and over
- Patient able to express free, informed and written consent
- Patient participating in the physical activity rehabilitation program at the CIMS of the Hôtel Dieu
- Patient suffering from a known, stable and diagnosed chronic disease
- Patient autonomous in taking treatments for their ALD
- Patient affiliated to a social security system
Exclusion Criteria:
- Patient under legal protection (guardianship, curatorship)
- Patient deprived of liberty by a judicial or administrative decision
- Patient with functional limitations that do not allow a physical assessment or result in a walking distance < 350 m during the HDJ for admission to the program
- Patient with suspected cardiac pathology during the HDJ for admission to the program
- Patient with episode of decompensation or exacerbation
- Patient with a pacemaker or implantable automatic defibrillator
- Pregnant women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard follow-up group
Routine care
|
|
|
Experimental: Connected scale group
Routine care + use of connected scale during 6 months
|
Patients in the intervention group will use the connected scale at a minimum frequency of once a week from receipt of the scale and throughout their participation in the research (6 months)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of the physical and mental quality of life score using the Short Form 36 questionnaire at 6 months for each patient.
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
Short Form 36 questionnaire (0 - 100 ; Higher mean better outcome)
|
6 months from initiation of physical activity rehabilitation program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of the physical and mental quality of life score using the Short Form 36 questionnaire at 6 weeks for each patient.
Time Frame: 6 weeks from initiation of physical activity rehabilitation program
|
Short Form 36 questionnaire (0 - 100 ; Higher mean better outcome)
|
6 weeks from initiation of physical activity rehabilitation program
|
|
Measurement of daily physical activity level by the Ricci & Gagnon questionnaire at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
Ricci & Gagnon questionnaire (9 - 45 ; Higher mean better outcome)
|
6 months from initiation of physical activity rehabilitation program
|
|
Measurement of 6 minute walk test (6MWT) at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
6 minute walk test (Higher mean better outcome)
|
6 months from initiation of physical activity rehabilitation program
|
|
Measurement of 30 sec sit-to-stand test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
30 sec sit-to-stand test (Higher mean better outcome)
|
6 months from initiation of physical activity rehabilitation program
|
|
Measurement of Ito-Shirado test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
Ito-Shirado test (Higher mean better outcome)
|
6 months from initiation of physical activity rehabilitation program
|
|
Measurement of Sorensen test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
Sorensen test (Higher mean better outcome)
|
6 months from initiation of physical activity rehabilitation program
|
|
Measurement of Handgrip test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
Handgrip test (Higher mean better outcome)
|
6 months from initiation of physical activity rehabilitation program
|
|
Measurement of VO2max at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
|
VO2
|
6 months from initiation of physical activity rehabilitation program
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP230549
- 2023-A01156-39 (Other Identifier: IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Body Comp Pro connected scale (Withings manufacturer)
-
Assistance Publique - Hôpitaux de ParisWithingsActive, not recruitingSurgery | Obesity, SevereFrance
-
Assistance Publique - Hôpitaux de ParisWithingsRecruitingLymphoma, Non-Hodgkin | Myeloma MultipleFrance
-
Assistance Publique - Hôpitaux de ParisBPIfrance; WithingsNot yet recruiting
-
Centre for Human Drug Research, NetherlandsFacio TherapeuticsCompleted
-
SERGIO MONTERO NAVARROCardenal Herrera University; CAPENERGY MEDICAL, SLRecruitingBreast Cancer | Physical Exercise | Radiofrequency | Genitourinary SyndromeSpain